***Participation Requested***
Sharing Responses to Health Canada’s Consultation on Proposed
Amendments to the Patented Medicines Regulations
In May 2017, Federal Minister of Health Jane Philpott, launched a consultation on proposed amendments to the Patented Medicines Regulations that would have significant effects on how patented ... Read More
News & Events
22
Aug2017
21
Aug2017
On August 18, 2017, the Institut national d’excellence en santé et en services sociaux (INESSS) released a Notice to Drug Manufacturers and Wholesalers describing the following changes to the INESSS process.
List Update Schedule in 2018
The Minister of Health and Social Services has authorized nine updates to the List ... Read More
14
Aug2017
On August 14, 2017, the Canadian Agency for Drugs and Technologies in Health (CADTH) released a new CDR Update (Issue 126) describing the following changes to the Common Drug Review (CDR) process.
Extended Initiation Range for December 2017 CDEC Meeting
CADTH has extended the initiation range for Common ... Read More
09
Aug2017
The pan-Canadian Pharmaceutical Alliance (pCPA) updated the status of negotiations on brand name drugs as of July 31, 2017:
46 negotiations are currently underway with 7 new files added since the last update of June 30, 2017:
Cinqair (reslizumab): Used to treat severe eosinophilic asthma
Giotrif (afatinib): Used to ... Read More
25
Jul2017
The following table provides the submission deadlines for the HDAP meetings in 2018:
HDAP Meeting Date
Filing Deadlines
Product Monograph (1)
Submission (2)
February 27, 2018
November 7, 2017
December 12, 2017
May 7, 2018... Read More
14
Jul2017
On July 13, 2017, the Canadian Agency for Drugs and Technologies in Health (CADTH) released a new CDR Update (Issue 124) describing the following changes.
CDEC Meeting Added in December 2017 and Updated CDEC Meeting Dates
CADTH will be holding a Canadian Drug Expert Committee (CDEC) meeting in December 2017 ... Read More
13
Jul2017
On July 11, 2017, the Executive Officer announced that as part of the 2017 Budget and the government’s ongoing commitment to provide better and faster access to high-quality health services, Ontario is proposing to create the OHIP+: Children and Youth Pharmacare Program.
Under this program, the province would, as of January ... Read More
11
Jul2017
The pan-Canadian Pharmaceutical Alliance (pCPA) updated the status of negotiations on brand name drugs as of June 30, 2017:
42 negotiations are currently underway with 6 new files added since the last update of May 31, 2017:
Caprelsa (vandetanib): Used to treat medullary thyroid cancer
Kyprolis (carfilzomib): Used to ... Read More
15
Jun2017
The pan-Canadian Pharmaceutical Alliance (pCPA) updated the status of negotiations on brand name drugs as of May 31, 2017:
43 negotiations are currently underway with 9 new files added since the last update of April 30, 2017:
Brivlera (brivarcetam): Used to treat partial-onset seizures
Butrans (buprenorphine): Used to treat ... Read More
13
Jun2017
The Minister of Health and Social Services has authorized one additional update to the List of Medications covered by the basic prescription drug insurance plan and the List of Medications – Institutions in 2018: February 1. The submission deadline for innovative drug products is August 11, 2017.
Please note that only ... Read More